Pryv Joins The Pistoia Alliance to Lower the Barriers of Adopting Innovation in Life Sciences Research and Development

PryvAs a new member at Pistoia Alliance, Pryv joins with the mission to address the growing needs for improving the adoption of innovative technologies for patient and real-world data. Positioning itself as the next industry standard for personal and real-world data standard, Pryv is looking forward to participating in the Pistoia Alliance Community to promote collaboration as many organisations would benefit significantly from industry-wide pre-competitive collaboration.

Still, one of the biggest challenges the industry has, is transforming the growing number of collected data sets into meaningful insights via developing and implementing machine and deep learning systems.

Pryv addresses this challenge by providing the industry with a technology solution that enables data collection and standardization, storage and distribution, while allowing different and multi-algorithms to be used to identify patterns and outcomes.

Used as a foundation of R&D products development, Pryv eHealth Middleware technology ensures fast access to data and its compliant usage cross-borders. Easy access to acquiring real-world data, designing real-world data platforms and delivering real-world evidence, while ensuring the data is managed properly: preserving data privacy and security first is the promise Pryv brings to the wider Life Science community.

Benefiting from the ready-to-be used Middleware solution of Pryv, Pharmaceutical and Life Science companies can focus now primarily on their research and deliver real benefits to patients while being sure the data management is done right under their control.

The blockchain technology Pryv developed, and implemented in its Middleware is used to validate data set genuineness through its full life-cycle and provide a data trail audit, while the unique data ontology allows for granular data distribution to each stakeholder respecting Ethical, Legal and Clinical Data Requirements.

For further information, please visit:
http://pryv.com

About Pryv
Pryv is an independent Swiss SME founded in 2012 with the mission to promote, develop and implement Health IT patient-centric solutions across the healthcare industry.Pryv developed and sell licenses of a trusted Swiss-made and validated eHealth Data Middleware to empower Pharmas, Hospitals/ Clinics, Medtech, Digital Health, Insurances to build compliant, innovative and scalable data-driven eHealth products with confidence, reduced time and IT expenses while respecting complex Data Privacy Regulations.

About The Pistoia Alliance
The Pistoia Alliance is a global, not-for-profit members' organisation made up of life science companies, technology and service providers, publishers, and academic groups working to lower barriers to innovation in life science and healthcare R&D. It was conceived in 2007 and incorporated in 2009 by representatives of AstraZeneca, GSK, Novartis and Pfizer who met at a conference in Pistoia, Italy. Its projects transform R&D through pre-competitive collaboration. It overcomes common R&D obstacles by identifying the root causes, developing standards and best practices, sharing pre-competitive data and knowledge, and implementing technology pilots. There are currently over 80 member companies; members collaborate on projects that generate significant value for the worldwide life sciences R&D community, using the Pistoia Alliance’s proven framework for open innovation.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

Brain Imaging may Identify Patients Like…

By understanding differences in how people’s brains are wired, clinicians may be able to predict who would benefit from a self-guided anxiety care app, according to a new analysis from...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...